Navigating the New EU Clinical Trial Regulation: 536/2014

The European Clinical Trial Regulation 536/2014 (CTR) will be coming into full effect in 2022, and will significantly change how companies conduct their trials. The CTR will replace the Clinical Trials Directive (2001/20/EC), which has been in effect since 2004.

In this whitepaper our panel discussed the changes, benefits and potential challenges that the new EU Clinical Trial Regulation No 536/2014 will bring when it is made effective. The team also reviewed how the CTR will different from the current EU Clinical Trials Directive 2001/20/EC which has been the principal legal directive in place since 2004, governing how clinical trials are conducted

To view this white paper, please complete the form below:

The trusted partner for global integrated CDMO services.

When it comes to pharmaceutical and biopharmaceutical supply chain expertise who do you trust?

Start your PCI experience today.

Your bridge between life-changing therapies and patients.